Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New-onset inflammatory bowel diseases among IL-17 inhibitor-treated patients: results from the case-control MISSIL study.
Letarouilly JG, Pham T, Pierache A, Acquacalda É, Banneville B, Barbarot S, Baudart P, Bauer É, Claudepierre P, Constantin A, Dernis E, Felten R, Gaudin P, Girard C, Gombert B, Goupille P, Guennoc X, Henry-Desailly I, Jullien D, Karimova E, Lanot S, Le Dantec L, Pascart T, Plastaras L, Sultan N, Truchet X, Varin S, Wendling D, Gaboriau L, Staumont-Sallé D, Peyrin-Biroulet L, Flipo RM. Letarouilly JG, et al. Rheumatology (Oxford). 2022 Jul 6;61(7):2848-2855. doi: 10.1093/rheumatology/keab819. Rheumatology (Oxford). 2022. PMID: 34730790
[Ustekinumab].
Jullien D, Staumont-Salle D; Groupe de recherche sur le psoriasis de la Société française de dermatologie. Jullien D, et al. Ann Dermatol Venereol. 2019 Jun-Jul;146(6-7):497-502. doi: 10.1016/j.annder.2019.04.014. Epub 2019 Jun 14. Ann Dermatol Venereol. 2019. PMID: 31208737 French. No abstract available.
Omalizumab in chronic inducible urticaria: A retrospective, real-life study.
Fialek M, Dezoteux F, Le Moing A, Karimova E, Ramdane N, Pape E, Azib-Meftah S, Staumont-Sallé D. Fialek M, et al. Ann Dermatol Venereol. 2021 Dec;148(4):262-265. doi: 10.1016/j.annder.2021.04.010. Epub 2021 Jul 8. Ann Dermatol Venereol. 2021. PMID: 34247853 No abstract available.
Self-reported Impact of the Early 2020 COVID-19 Crisis on the Healthcare Pathway During and After Lockdown in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Practical Survey.
Nasseh J, Podevin C, Ternynck C, Zephir H, Letarouilly JG, Flipo RM, Nachury M, Chenivesse C, Hachulla E, Launay D, Staumont-Salle D, Dezoteux F. Nasseh J, et al. J Patient Exp. 2022 Dec 8;9:23743735221143736. doi: 10.1177/23743735221143736. eCollection 2022. J Patient Exp. 2022. PMID: 36518727 Free PMC article.
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort.
Faiz S, Giovannelli J, Podevin C, Jachiet M, Bouaziz JD, Reguiai Z, Nosbaum A, Lasek A, Ferrier le Bouedec MC, Du Thanh A, Raison-Peyron N, Tetart F, Duval-Modeste AB, Misery L, Aubin F, Dompmartin A, Morice C, Droitcourt C, Soria A, Arnault JP, Delaunay J, Mahé E, Richard MA, Schoeffler A, Lacour JP, Begon E, Walter-Lepage A, Dillies AS, Rappelle-Duruy S, Barete S, Bellon N, Bénéton N, Valois A, Barbarot S, Sénéchal J, Staumont-Sallé D; Groupe de Recherche sur l'Eczéma aTopique (GREAT), France. Faiz S, et al. J Am Acad Dermatol. 2019 Jul;81(1):143-151. doi: 10.1016/j.jaad.2019.02.053. Epub 2019 Feb 27. J Am Acad Dermatol. 2019. PMID: 30825533
A new phototherapy regimen during winter as an add-on therapy, coupled with oral vitamin D supplementation, for the long-term control of atopic dermatitis: study protocol for a multicentre, randomized, crossover, pragmatic trial - the PRADA trial.
Droitcourt C, Barbarot S, Maruani A, Darrieux L, Misery L, Brenaut E, Adamski H, Chabbert C, Vermersch A, Weiborn M, Seneschal J, Taïeb A, Plantin P, Maillard H, Phan A, Skowron F, Viguier M, Staumont-Salle D, Nosbaum A, Soria A, Barbaud A, Oger E, Dupuy A; Groupe de Recherche sur l’Eczéma Atopique de la Société Française de Dermatologie (GREAT). Droitcourt C, et al. Trials. 2019 Mar 25;20(1):184. doi: 10.1186/s13063-019-3276-9. Trials. 2019. PMID: 30909923 Free PMC article.
Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patients.
Calugareanu A, Jachiet M, Tauber M, Nosbaum A, Aubin F, Misery L, Droitcourt C, Barbarot S, Debarbieux S, Saussine A, Bagot M, de Masson A, Sénéschal J, Staumont-Sallé D, Bouaziz JD; French Group of Research and Study in Atopic Dermatitis (Groupe de Recherche sur l'Eczéma Atopique, GREAT) from the French Society of Dermatology (SFD). Calugareanu A, et al. J Eur Acad Dermatol Venereol. 2020 Feb;34(2):e74-e76. doi: 10.1111/jdv.15957. Epub 2019 Oct 17. J Eur Acad Dermatol Venereol. 2020. PMID: 31529718 No abstract available.
Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis.
Marcant P, Balayé P, Merhi R, Jendoubi F, Nosbaum A, Raison-Peyron N, Du-Thanh A, Lasek A, Ferrier le Bouedec MC, Tetart F, Valois A, Barbarot S, Soria A, Jachiet M, Staumont-Sallé D; GREAT Research Group. Marcant P, et al. J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e394-e396. doi: 10.1111/jdv.17177. Epub 2021 Mar 5. J Eur Acad Dermatol Venereol. 2021. PMID: 33594731 No abstract available.
124 results